SOPHiA GENETICS (SOPH) EBT Margin (2020 - 2025)

SOPHiA GENETICS has disclosed EBT Margin across 6 years of filings, most recently posting 90.17% for Q4 2025.

• EBT Margin for Q4 2025 came in at 90.17%, down 817.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 100.28% (down 627.0% YoY), and the FY2025 annual result was 100.28%, down 627.0% from the prior year.
• EBT Margin came in at 90.17% for Q4 2025 at SOPHiA GENETICS, up from 99.57% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 82.01% in Q4 2024 to a low of 232.52% in Q1 2022.
• The 5-year median for EBT Margin is 128.68% (2025), against an average of 137.89%.
• Across the five-year window, EBT Margin tumbled 9334 bps in 2022 and jumped 11806 bps in 2023, its largest moves.
• SOPHiA GENETICS's EBT Margin stood at 200.23% in 2021, then jumped by 47 bps to 106.31% in 2022, then tumbled by 33 bps to 141.08% in 2023, then surged by 42 bps to 82.01% in 2024, then slipped by 10 bps to 90.17% in 2025.
• The last three EBT Margin figures came in at 90.17% (Q4 2025), 99.57% (Q3 2025), and 118.17% (Q2 2025), per Business Quant data.